Reflow Medical Receives CE Mark for Bare Temporary Spur Stent System for Treating de novo or Restenotic Below-the-Knee (BTK) Lesions
SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Jan 16, 2024--
Source: eagletribune.com
Stay updated with breaking news from Isa Rizk. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Jan 16, 2024--
Reflow Medical, Inc. announces that it has completed patient enrollment in the DEEPER OUS clinical trial (NCT03807531) for the company's Temporary Spur Stent System, a novel device that features a retrievable
Press release content from Business Wire. The AP news staff was not involved in its creation.